Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
Feng Y, Gordts SC, Chen F, Hu Y, Van Craeyveld E, Jacobs F, Carlier V, Feng Y, Zhang Z, Xu Q, Ni Y, De Geest B.
Feng Y, et al. Among authors: gordts sc.
Atherosclerosis. 2011 Feb;214(2):271-8. doi: 10.1016/j.atherosclerosis.2010.09.024. Epub 2010 Sep 29.
Atherosclerosis. 2011.
PMID: 20943224